Furthermore, in vivo anti-glioma experiments with C6 glioma-bearing rats demonstrated that TBE-loaded anti-EPHA3-decorated NPs induced markedly higher tumor cell apoptosis and prolonged the median survival time compared to controls. Here, EPHA3 is linked to central nervous system cancer.